APA (7th ed.) Citation

Di Cosimo, S., Silvestri, M., Dugo, M., Vismara, M., Reduzzi, C., Pruneri, G., . . . Daidone, M. (2020). 59P Primary tumour and circulating tumour cell (CTC) copy number alterations (CNAs) in triple negative breast cancer (TNBC) patients (pts) treated with neoadjuvant chemotherapy (NAC). Annals of Oncology, 31, S35. https://doi.org/10.1016/j.annonc.2020.03.193

Chicago Style (17th ed.) Citation

Di Cosimo, S., M. Silvestri, M. Dugo, M. Vismara, C. Reduzzi, G. Pruneri, S. Folli, V. Cappelletti, and M.G Daidone. "59P Primary Tumour and Circulating Tumour Cell (CTC) Copy Number Alterations (CNAs) in Triple Negative Breast Cancer (TNBC) Patients (pts) Treated with Neoadjuvant Chemotherapy (NAC)." Annals of Oncology 31 (2020): S35. https://doi.org/10.1016/j.annonc.2020.03.193.

MLA (9th ed.) Citation

Di Cosimo, S., et al. "59P Primary Tumour and Circulating Tumour Cell (CTC) Copy Number Alterations (CNAs) in Triple Negative Breast Cancer (TNBC) Patients (pts) Treated with Neoadjuvant Chemotherapy (NAC)." Annals of Oncology, vol. 31, 2020, p. S35, https://doi.org/10.1016/j.annonc.2020.03.193.